Saurabh Dahiya

2 months ago | onclive.com | Shyam Patel |Saurabh Dahiya

Welcome to OncLive On Air®! I’m your host today, Ashling Wahner. OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. In today’s episode, we had the pleasure of speaking with Saurabh Dahiya, MD, FACP, and Shyam A.

May 16, 2024 | onclive.com | Saurabh Dahiya

Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division, discusses the significance of the FDA approval of lisocabtagene maraleucel (liso-cel; Breyanzi) for patients with relapsed/refractory follicular lymphoma (FL).

Jul 25, 2023 | pubmed.ncbi.nlm.nih.gov | Jenny Gao |Saurabh Dahiya |Shyam Patel

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software

Jul 24, 2023 | onlinelibrary.wiley.com | Jenny Gao |Saurabh Dahiya |Shyam Patel

Corresponding Author Shyam A. Patel Division of Hematology/Oncology, Department of Medicine, UMass Memorial Medical Center, Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, Massachusetts, USA Correspondence Shyam A. Patel, Division of Hematology/Oncology, Department of Medicine, UMass Memorial Medical Center, Center for Clinical and Translational Science, UMass Chan Medical School, 55 Lake Ave. North, Worcester, MA 01655, USA.